La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Austar Lifesciences Bilan de santé
Santé financière contrôle des critères 3/6
Austar Lifesciences possède un total de capitaux propres de CN¥775.5M et une dette totale de CN¥430.7M, ce qui porte son ratio d'endettement à 55.5%. Son actif total et son passif total sont CN¥2.2B et de CN¥1.4B.
Informations clés
49.5%
Ratio d'endettement
CN¥386.27m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | CN¥139.98m |
| Fonds propres | CN¥780.63m |
| Total du passif | CN¥1.36b |
| Total des actifs | CN¥2.14b |
Mises à jour récentes de la santé financière
Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28
We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Recent updates
Investors Aren't Buying Austar Lifesciences Limited's (HKG:6118) Revenues
Aug 28We Think Shareholders May Want To Consider A Review Of Austar Lifesciences Limited's (HKG:6118) CEO Compensation Package
May 24Revenues Working Against Austar Lifesciences Limited's (HKG:6118) Share Price Following 30% Dive
Apr 18Would Austar Lifesciences (HKG:6118) Be Better Off With Less Debt?
Mar 28Investors Still Aren't Entirely Convinced By Austar Lifesciences Limited's (HKG:6118) Revenues Despite 25% Price Jump
Feb 12Market Cool On Austar Lifesciences Limited's (HKG:6118) Revenues
Dec 22We Think Austar Lifesciences (HKG:6118) Has A Fair Chunk Of Debt
Sep 28Here's Why Austar Lifesciences (HKG:6118) Has A Meaningful Debt Burden
Mar 31Austar Lifesciences Limited (HKG:6118) Stock's 29% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Sep 19Is Austar Lifesciences (HKG:6118) A Risky Investment?
Apr 06Austar Lifesciences (HKG:6118) Has A Pretty Healthy Balance Sheet
Oct 24With EPS Growth And More, Austar Lifesciences (HKG:6118) Is Interesting
Sep 27If You Like EPS Growth Then Check Out Austar Lifesciences (HKG:6118) Before It's Too Late
May 31Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Mar 31Is Now The Time To Put Austar Lifesciences (HKG:6118) On Your Watchlist?
Mar 01Austar Lifesciences Limited (HKG:6118) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
Feb 01
Are Austar Lifesciences's (HKG:6118) Statutory Earnings A Good Guide To Its Underlying Profitability?
Jan 11Austar Lifesciences (HKG:6118) Seems To Use Debt Quite Sensibly
Dec 21Can You Imagine How Jubilant Austar Lifesciences' (HKG:6118) Shareholders Feel About Its 191% Share Price Gain?
Dec 07Here's What Austar Lifesciences Limited's (HKG:6118) Shareholder Ownership Structure Looks Like
Nov 23Analyse de la situation financière
Passif à court terme: Les actifs à court terme de 6118 ( CN¥1.6B ) dépassent ses passifs à court terme ( CN¥1.2B ).
Passif à long terme: Les actifs à court terme de 6118 ( CN¥1.6B ) dépassent ses passifs à long terme ( CN¥205.8M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de 6118 ( 33.1% ) est considéré comme satisfaisant.
Réduire la dette: Le ratio d'endettement de 6118 est passé de 5.4% à 55.5% au cours des 5 dernières années.
Couverture de la dette: La dette de 6118 n'est pas bien couverte par le flux de trésorerie opérationnel ( 5.6% ).
Couverture des intérêts: Données insuffisantes pour déterminer si les paiements d'intérêts de 6118 sur sa dette sont bien couverts par l'EBIT.